Want to see AZTA full AI Analyst Report?
Segment Adjusted Operating Income Breakdown
Reveals which segments contribute real operating profit after adjustments, making it clear which businesses are economically successful and which are loss-making or margin-constrained. Useful for seeing where cost control, pricing power, or further investment will most affect Azenta’s overall profitability and return on capital.
Operating income shows Azenta moving away from legacy semiconductor and B Medical contributions toward Sample Management Solutions as the core profit driver—SMS flipped to sustained positive operating income in 2024–2026—while Multiomics, despite revenue growth, continues to consume EBITDA as investments, Sanger declines and margin pressure persist. The B Medical divestiture removes a past drag and management’s raised FY26 guidance and sequential EBITDA improvement signal recovery, but automated-store remediation costs and UK Biocentre integration could squeeze SMS margins near term.
AZTA Segment Adjusted Operating Income Breakdown
| Date | Semiconductor Solutions | Life Sciences Products | Life Sciences Services | Sample Management Solutions | Multiomics | B Medical Systems |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $0.00 | $0.00 | $0.00 | $4.94M | -$348.00K | $0.00 |
| Mar 31, 2026 | $0.00 | $0.00 | $0.00 | $3.12M | -$10.07M | $0.00 |
| Dec 31, 2025 | $0.00 | $0.00 | $0.00 | $4.98M | -$4.36M | $0.00 |
| Sep 30, 2025 | $0.00 | $0.00 | $0.00 | $9.37M | -$807.00K | $0.00 |
| Jun 30, 2025 | $0.00 | $0.00 | $0.00 | $11.25M | -$3.33M | $0.00 |
| Mar 31, 2025 | $0.00 | $0.00 | $0.00 | $4.61M | -$5.30M | $0.00 |
| Dec 31, 2024 | $0.00 | $0.00 | $0.00 | $2.32M | -$2.50M | $0.00 |
| Sep 30, 2024 | $0.00 | $0.00 | $0.00 | $9.86M | -$848.00K | -$2.02M |
| Jun 30, 2024 | $0.00 | $0.00 | $0.00 | $3.40M | -$730.00K | $1.91M |
| Mar 31, 2024 | $0.00 | $0.00 | $0.00 | -$1.57M | -$2.97M | -$1.15M |
| Dec 31, 2023 | $0.00 | $0.00 | $0.00 | -$856.00K | -$3.45M | -$4.41M |
| Sep 30, 2023 | $0.00 | $55.40M | -$1.42M | $0.00 | $0.00 | $0.00 |
| Jun 30, 2023 | $0.00 | -$4.88M | -$3.81M | $0.00 | $0.00 | $0.00 |
| Mar 31, 2023 | $0.00 | -$16.40M | -$4.88M | $0.00 | $0.00 | $0.00 |
| Dec 31, 2022 | $0.00 | -$3.80M | -$4.61M | $0.00 | $0.00 | $0.00 |
| Sep 30, 2022 | $0.00 | -$859.00K | -$4.21M | $0.00 | $0.00 | $0.00 |
| Jun 30, 2022 | $0.00 | $2.22M | $2.25M | $0.00 | $0.00 | $0.00 |
| Mar 31, 2022 | $0.00 | $5.29M | $4.86M | $0.00 | $0.00 | $0.00 |
| Dec 31, 2021 | $0.00 | $4.39M | $7.88M | $0.00 | $0.00 | $0.00 |
| Sep 30, 2021 | $0.00 | -$5.20M | -$18.84M | $0.00 | $0.00 | $0.00 |
| Jun 30, 2021 | $44.80M | $9.14M | $13.78M | $0.00 | $0.00 | $0.00 |
| Mar 31, 2021 | $33.30M | $11.21M | $13.41M | $0.00 | $0.00 | $0.00 |
| Dec 31, 2020 | $21.54M | $7.94M | $14.31M | $0.00 | $0.00 | $0.00 |
